Immunity Pharma
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Jerusalem, Jerusalem, IsraelWebsite
www.immunitypharma.comRevenue
<$5 MillionIndustry
About Immunity Pharma
Immunity Pharma is a clinical-stage biopharmaceutical company focused on developing innovative compounds that enhance therapeutic cell-signaling processes for the treatment of neurodegenerative diseases, with an initial emphasis on ALS (Lou Gehrig's disease). The company is dedicated to advancing its pipeline through clinical trials, including recent positive results from a phase-2a trial of its product IPL344. Their mission is to provide effective treatments that can slow disease progression and improve patient outcomes. Immunity Pharma aims to serve patients suffering from neurodegenerative conditions, particularly those affected by ALS.Explore more
SIC Code 28,283NAICS Code 32,325Show moreImmunity Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Immunity Pharma Tech Stack
A closer look at the technologies used by Immunity Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Immunity Pharma
Sign Up For FreeTo access detailed company insights
Immunity Pharma is a clinical-stage biopharmaceutical company focused on developing innovative compounds that enhance therapeutic cell-signaling processes for the treatment of neurodegenerative diseases, with an initial emphasis on ALS (Lou Gehrig's disease). The company is dedicated to advancing its pipeline through clinical trials, including rece... Read More
